EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Immunosuppression for adult steroid-dependent or frequently relapsing nephrotic syndrome: A systematic review and meta-analysis

Zhi Yong Wong iD, Chiu Yee Teo iD, Yan Qi Fiona Wong, Ka Ting Ng, Soo Kun Lim iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0307981 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift PLOS ONE, 2024. Verfasst von Zhi Yong Wong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. Hauptthemen laut MEDLINE: Nephrotic Syndrome, Immunosuppressive Agents. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

There is limited evidence on which immunosuppressive agents produce the best outcomes for adult patients with steroid-dependent or frequently relapsing nephrotic syndrome (SDNS/FRNS). This review compares the remission rate and adverse effects of various immunosuppressants used.

Methods

Studies of adult patients with biopsy-proven SDNS/FRNS, administered any immunosuppressive agents and reported complete remission results as one of the clinical outcomes were included. Articles were independently screened by two researchers. ROBINS-I was used for risk of bias assessment. Random-effects model was used for statistical analysis and corresponding 95% confidence intervals (CIs) were calculated.

Results

574 patients across 28 studies were included in the analysis. Patients receiving rituximab have a complete remission rate of 89% (95% CI = 83% to 94%; τ2 = 0.0070; I2 = 62%; overall p < 0.01, low certainty) and adverse event rate of 0.26, cyclosporine (CR 40%; 95% CI = 21% to 59%; τ2 = 0.0205; I2 = 55%; overall p = 0.08, low certainty), tacrolimus (CR 84%; 95% CI = 70% to 98%; τ2 = 0.0060; I2 = 33%; overall p = 0.21, moderate certainty), mycophenolate mofetil (CR 82%; 95% CI = 74% to 90%; τ2 < 0.0001; I2 = 15%; overall p = 0.32, moderate certainty) and cyclophosphamide (CR 79%; 95% CI = 69% to 89%; τ2 = 0; I2 = 0%; overall p = 0.52, moderate certainty).

Conclusion

Among the commonly used immunosuppressive agents, only rituximab has a statistically significant effect in achieving complete remission among patients with SDNS/FRNS and has a relatively good safety profile, but this is limited by low quality of evidence with high degree of heterogeneity causing a lack of statistical power.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nephrotic SyndromeImmunosuppressive AgentsHumansAdultRecurrenceRituximabSteroidsImmunosuppression TherapyRemission InductionTreatment Outcome

Substanzen

Immunosuppressive AgentsRituximabSteroids

Autor:innen und Institutionen

  • Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
  • Faculty of Medicine, Department of Anesthesiology, University of Malaya, Kuala Lumpur, Malaysia.
  • Faculty of Medicine, Department of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

ORCID-Profile: Zhi Yong Wong, Chiu Yee Teo, Soo Kun Lim

Zitieren

APA

Wong, Z. Y., Teo, C. Y., Fiona Wong, Y. Q., Ng, K. T., & Lim, S. K. (2024). Immunosuppression for adult steroid-dependent or frequently relapsing nephrotic syndrome: A systematic review and meta-analysis. PLOS ONE. https://doi.org/10.1371/journal.pone.0307981

Vancouver

Wong ZY, Teo CY, Fiona Wong YQ, Ng KT, Lim SK. Immunosuppression for adult steroid-dependent or frequently relapsing nephrotic syndrome: A systematic review and meta-analysis. PLOS ONE. 2024. doi:10.1371/journal.pone.0307981

BibTeX
@article{Wong2024,
  author = {Wong, Zhi Yong and Teo, Chiu Yee and Fiona Wong, Yan Qi and Ng, Ka Ting and Lim, Soo Kun},
  title = {Immunosuppression for adult steroid-dependent or frequently relapsing nephrotic syndrome: A systematic review and meta-analysis},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0307981}
}
Kostenlos starten →